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1. Introduction 
In the last decade, significant research efforts were devoted to obtaining materials with well-
defined nanostructures for a wide range of applications (Hamley, 2003; Soler-Illia et al., 
2002; Paul & Sharma, 2006). Mesoporous silica materials like M41S, HMS, SBAn, FSM, and 
MSU, among others, are a fairly new type of material that has pores in the mesoscopic range 
of 2–50 nm (Wan et al., 2007). The characteristic features of ordered mesoporous materials 
are their monodispersed and adjustable pore size in an inert and biocompatible matrix with 
an easily modified surface.  
Procedures to obtain ordered mesoporous silicates rely on the micelle-forming properties of 
a surfactant, whose chemical composition, size, and concentration control the structural 
dimensions of the final material (Zhao et al., 1998). In most cases, ionic and neutral 
surfactants have been employed as templates to direct mesophase formation based on the 
electrostatic and hydrogen-bonding interaction. Polymerization of the inorganic precursor 
and further removal of the surfactants result in a rigid silica shell that delimits the structural 
shape of the mesopores. In such processing routes, the resultant material presents an 
ordered hexagonal arrangement of unidirectional mesoporous channels and a high surface 
area, above 800 m2/g, depending on the synthesis conditions. Figure 1 shows the scheme of 
structure formation mediated by inorganic mesoporous structure-directing agent. 
The intrinsic uniform porous structure of this class of compounds with their large specific 
surface area and pore volume, associated with surface silanol groups, give these materials a 
significant potential for applications as matrices of many chemical species, such as organic 
molecules, metals, and polymeric materials. The combination of different materials to obtain 
nanocomposites is of great research interest due to their potential medical applications, such 
as tissue engineering, drug delivery devices, and hyperthermia, among others (Vallet-Regi 
et al., 2008; Souza et al., 2010).  
In this work, the recent developments in nanocomposites based on mesoporous materials 
(also referred to as hybrid materials) will be overviewed. Two categories of nanocomposites 
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will be described: (1) mesoporous silica with magnetic nanoparticles and (2) mesoporous 
silica with polymers included. The recent progress and applications of each one of these 
materials in the biomedical field will be reported.  
 
 
Fig. 1. Scheme of structure formation mediated by inorganic mesoporous structure-directing 
agent. (A) Formation of liquid crystal from surfactant and (B) self-organizing cooperative 
process.  
2. General aspects 
The performance of these materials in many fields of applications depends directly on the 
silica network porosity. Because of their large pores, high hydrothermal stability, and easy 
preparation, SBA-15 materials have been considered very promising for hosting and further 
delivery under appropriate conditions of a variety of molecules of pharmaceutical interest 
(Sousa et al., 2004). The delivery of these molecules was once considered difficult, because of 
the difficulty associated with the diffusion of large molecules through the materials of 
conventional drug delivery systems (DDS). These organic substances are normally very large 
in size and mesoporous silica is a potential candidate to encapsulate such molecules by 
utilizing ordered mesopores. Indeed, the properties of the formed solids are extremely 
dependent on the synthesis temperature, and the properties of surfactants used as templates in 
the synthesis are reflected in several properties of the final solid. In this way, structural 
characteristics such as pore size and porosity can be altered by change in some of the synthesis 
parameters. Consequently, the release kinetics from the matrix, due to its well-arranged 
structure, can be altered by change in the textural characteristics. Nevertheless, there is one 
major problem for the mesoporous systems as far as drug release is concerned, and that is the 
limited control of the drug release whose major mechanism is diffusion. The need to create 
new materials with optimized, predetermined characteristics has spurred an increasing 
interest in hybrid materials, especially in organic and inorganic nanocomposites.  
The development of new delivery systems has proven to be of great interest for 
pharmaceutical technology. Ceramic materials generally release drugs by the following 
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mechanisms: (i) diffusion, (ii) chemical reaction, or (iii) solvent activation. Beyond these, 
some systems can by externally activated to release more drugs when necessary, using 
external forces such as magnetism or temperature. 
In the case of magnetism as an external force, the first type of nanocomposites that will be 
presented in this chapter, small magnetic beads are uniformly dispersed within a matrix. 
When these nanoparticles are exposed to a biological system, normal diffusion of the drug 
occurs due to a concentration gradient. However, upon exposure to an external oscillating 
magnetic field, larger quantities of drug can be released quickly. This nanocomposite 
combines the special structural characteristics of mesoporous silica matrix with the 
advantages of the unique magnetic properties of magnetic nanoparticles, because the 
unprotected magnetic nanoparticles can easily form aggregates and react with oxygen 
present in the air. Therefore, a suitable coating with mesoporous silica is essential to prevent 
such limitation. These materials seem suited for numerous in vivo applications, such as 
tumor hyperthermic treatment and magnetic drug targeting (Souza et al., 2009; Souza et al., 
2010). Magnetic drug targeting allows the release of drugs at a defined target site with the 
aid of a magnetic field. The concept of hyperthermia is to heat a region of the body affected 
by cancer to temperatures between 43 and 45 ºC. At these temperatures, the growth of 
cancerous cells can be halted.  
 In the case of temperature as an external force for diffusion, which is the second category 
that will be presented in this chapter, the systems are hybrid. Several studies have reported 
the encapsulation of polymers into mesoporous silica hosts. Encapsulation of stimuli-
responsive polymers has been of particular interest in the drug delivery area. Among these 
stimuli-responsive polymers, temperature-responsive hydrogels such as poly(N-
isopropylacrylamide) [P(N-iPAAm)] are a well-studied class of drug delivery systems, as 
they can respond strongly to temperature changes. In water, P(N-iPAAm) exhibits a phase 
transition at a lower critical solution temperature (LCST) of approximately 33ºC (Freitas & 
Cussler, 1987). Below the LCST, the hydrogel incorporates water and swells, whereas the 
release of water in response to an increase in temperature causes shrinkage. Thus, the 
development of hybrid functional nanosystems based on silica-P(N-iPAAm) has drawn 
much attention to the control of molecular transport, including drug release, because self-
regulated delivery allows for drug release when it is needed (Sousa et al., 2010). 
3. Magnetic nanocomposites and bioapplications 
The nanostructured silica has gained importance for biomedical applications and has been 
studied extensively. Silica has well established chemistries that allow surface modification 
with various functional groups (e.g., amine, thiol, carboxyl, and methacrylate). These 
nanoparticles can be further modified with biomolecules such as enzymes, proteins, DNA 
molecules, etc., for biological applications. The surface modification with biomolecules 
allows for the specific recognition of immobilized and free species, can provide diagnostic 
information, and serve as part of a purification or separation process (Jin et al., 2003). 
Another type of material that gained prominence in biological applications is magnetic 
nanoparticles. The synthesis of nanostructured magnetic materials has been intensively 
pursued because of their broad applications, including in magnetic storage media, catalysis, 
ferrofluids, contrast materials for magnetic resonance imaging, magnetic bioseparation, and 
magnetic carriers for drug targeting (Pankhurst et al., 2003), among others. 
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The application of the different forms of iron oxides for diagnostic procedures has gained 
wide acceptance in radiological practice, but therapeutic applications are still under 
investigation. Such applications have exploited two major advantages of iron oxides: their 
low toxicity to humans and the possibility of controlling their magnetization. For example, 
many of the particles used are superparamagnetic that can be easily magnetized with an 
external magnetic field, and when the field is removed, they do not exhibit residual 
magnetization. If exposed to an alternating magnetic field, the iron oxide particles become 
powerful heat sources by transforming the energy from the magnetic field into heat 
(Chastellain et al., 2004; Jordan et al., 1997). The most important characteristic of magnetic 
nanoparticles for heat generation is particle size (Kalambur et al., 2005). The greatest 
difficulty in the synthesis of ultrafine particles is size control on the nanometric scale. Thus, 
the research of easy and flexible magnetic synthetic routes to produce nanoparticles with 
desired sizes and acceptable size distribution without particle aggregation is of extreme 
importance to fulfill the potential of these materials in biomedical applications.  
Iron oxide (either Fe3O4 or γ-Fe2O3) can be synthesized through the co-precipitation of Fe2+ 
and Fe3+ aqueous salt solutions by addition of a base. The control of size, shape, and 
composition of nanoparticles depends on the type of salts used (e. g. chlorides, sulphates, 
nitrates, perchlorates, etc.), Fe2+ and Fe3+ ratio, pH, and ionic strength of the media (Gupta & 
Gupta, 2005). 
Other methods to prepare magnetite nanoparticles are microemulsion (Liu & Wang, 2004a), 
electrochemical synthesis (Franger et al., 2004), pyrolysis (Gun’ko et al., 2001), and 
hydrothermal synthesis (Wu et al., 2005). However, most methods present some synthesis 
problems, such as difficulties in the prevention of flocculation, the control of Fe2+ and Fe3+ 
ratio in the co-precipitation process, and the removal of surfactants in the micron-emulsion 
process. Recently, an oxidation-precipitation method for the preparation of magnetite 
nanoparticles has been used by some researchers (Thapa et al, 2004). The formation of Fe3O4 
follows the nucleation-growth mechanism when the Fe(OH)2/Fe(OH)3 molar ratio is 1:2, 
which is the characteristic value of the magnetite structure. However, it does require the 
careful adjustment of the solution pH value for particle formation and stabilization, and it is 
difficult to control particle size and size distribution.  
As discussed, for an efficient performance, the particles must remain non-aggregated, be 
stable against oxidation, and display high magnetization during application. Thus, 
appropriate nanoparticle coating is essential to overcome this limitation. Silica/iron oxide 
nanocomposites are of particularly interest, since the protective layer afforded by silica can 
prevent dipolar magnetic attraction between magnetite particles, and consequently produce 
quite uniform particle dispersion. 
The approaches for the synthesis of SiO2–Fe2O3 nanocomposites are varied (Ma et al., 2006; 
Chen et al., 2008). Such nanocomposites are composed of magnetic nanoparticles embedded 
or encapsulated in an inorganic oxide matrix. In addition, to coat the surface of magnetic 
nanoparticles, silica is obtained by classical sol–gel methods, but in this case, the final 
product may present a wide pore size distribution (Singh, 2008). The new class of 
nanocomposites, which combine special structural characteristics of mesoporous silica 
matrix with the advantages of the unique magnetic properties of iron nanoparticles, seems 
suited for numerous in vivo applications, such as tumor hyperthermic treatment and drug 
delivery. Most importantly, particle growth can be effectively confined to the channels of 
mesoporous silica, limiting particle size to the nanoscale.  
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Studies concerning the growth of Fe3O4 and γ-Fe2O3 nanoparticles inside mesoporous silica 
MCM-41 and MCM-48, using an ionic surfactant as a template, have also been reported 
(Köhn et al., 2003; Fellenz et al., 2006a). More recently, Fe3O4 nanoparticles modified 
covalently with triethoxysilane having a quaternarydicetylammonium ion were used as 
building blocks and incorporated in the structure (Alvaro et al., 2006). The surface of these 
nanoparticles was modified to become compatible with the structure-directing agent 
(cetyltrimethylammonium). However, these approaches result in materials presenting two 
main limitations: (i) due to the use of ionic surfactants, they present typical wall thicknesses 
around 1 nm (Doadrio et al., 2006) and consequently, low stability; (ii) the functionalization 
of the mesoporous surface and nanoparticle surface leads to a decrease in the pore size and 
surface area (Alvaro et al., 2006), facts that could affect the applicability of such materials in 
adsorption systems, like drug delivery systems.  
In this context, we reported the synthesis of mesoporous SiO2-coated Fe3O4 nanoparticles by 
using a neutral surfactant and without the application of any functionalization method 
(Souza et al., 2008). To accomplish this, the Fe3O4 nanoparticles were synthesized by 
oxidation–precipitation and coated with mesoporous silica (SBA-15) by using nonionic block 
copolymer surfactants as the structure-directing agent. We observed that the magnetite 
nanoparticles were completely and homogeneously coated by well-ordered mesoporous 
silica with stable (~8 nm thick) pore walls, Figure 2. The applied synthesis route did not 
affect the structural and magnetic properties of the Fe3O4 nanoparticles.  
In the other report, we presented a wet impregnation method which proved efficient to 
obtain well-dispersed Fe3O4 nanoparticles inside the pores of silica (Souza et al. 2010). The 
proposed method involved the preparation of an iron oxide precursor in ethanol and its 
subsequent transfer to SBA-15 mesoporous hexagonal silica. Iron oxide was formed inside 
the porous structure to obtain a magnetic material, Figure 3. The sample was heated to 550 
ºC for 2 h in air for the formation of iron oxide and then was heated to 550 ºC for 8 h in an N2 
atmosphere to obtain Fe3O4. 
The main methods of synthesis of composites using magnetic oxides dispersed in silica 
matrix and their various applications will be discussed below, having in mind the growing 
interest in using these materials in the biological area. 
 
  
(a)                                                                 (b) 
Fig. 2. Transmission electron micrographs: (a) Low resolution and (b) high resolution images 
showing the magnetite nanoparticles (dark region) covered by the mesoporous silica; the 
inset in (a) is the quantification of the size distribution of the Fe3O4 particles.  
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            (a)                                                           (b) 
Fig. 3. TEM of unidirectional canals of the open mesoporous structure, and image showing 
the magnetite nanoparticles (dark region) covered by mesoporous silica. 
3.1 Bioseparation 
Magnetic separation provides a convenient method for the removal of magnetizable 
particles by applying an appropriate magnetic field. In 1973 Robinson et al. used magnetic 
separation for the first time in a biotechnology context. In their work, silica-coated magnetic 
iron oxide and cellulose-coated magnetic iron oxide were used to immobilize two enzymes, 
α-chymotrypsin and β-galactosidase, for applications in bioreactors. Since then, magnetic 
separation has become an increasingly popular tool for the separation of biological 
molecules and cells (Bruce et al., 2004).  
If the magnetic material surface is selective for a specific protein, it will be able to connect to 
this surface, and its separation from the biological environment could be done by using a 
magnet (Figure 4). Once the surface has been modified, a system comprised of a magnetic 
core coated with silica can be used for bioseparation. 
 
 
Fig. 4. Scheme illustrating steps involved in the extraction of biomolecules using magnetic 
bioseparation agents. 
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The first bioseparation work onto a functionalized silica support was performed by Zhao 
and coworkers in 2003 (Zhao et al., 2003). The authors developed a novel genomagnetic 
nanocapturer (GMNC) for the collection, separation, and detection of trace amounts of 
DNA/RNA molecules with one single-base difference. The GMNC was constructed by 
bioconjugating molecular beacon DNA probes onto magnetic nanoparticle surfaces. The 
method showed an excellent ability to differentiate single-base mismatched DNA/mRNA 
samples by combining the exceptional specificity of molecular beacons and the separation 
power of magnetic nanoparticles. 
Later, Liu and coworkers synthesized magnetite (Fe3O4) nanoparticles by the coprecipitation 
method and coated their surface with silica, obtaining well dispersed magnetic silica 
nanospheres of about 50–80 nm in diameter. The surface of these nanospheres was 
functionalized with amino-silane coupling agent, N-(2-aminoethyl)-3-
aminopropyltrimethoxysilane (AEAPS) (Liu et al., 2004b). The functionalized silica has 
undergone a series of experiments performed to investigate the protein immobilization in a 
magnetic matrix. Bovine serum albumin (BSA) was chosen as a model protein and was 
covalently immobilized onto the amino-silane modified magnetic silica supports. The result 
shows that such amino-silane modified magnetic silica is a well-dispersed and effective 
superparamagnetic support for bioseparation with maximum BSA immobilization capacity 
(up to 86 mg/g), presenting, thus, potential use as immune-magnetic support for protein 
purification.  
Sen et al. (2006) reported the template-assisted fabrication of a magnetic mesoporous silica-
magnetite nanocomposite and its potential for application in magnetic bioseparations, 
evaluating its ability (i) to bind and elute DNA and (ii) to extract RNA from bacterial cells. 
Magnetite nanoparticles previously synthesized were used as a core material for the 
fabrication of a mesoporous magnetic nanocomposite. Both core magnetite and silica-
magnetite nanocomposite demonstrated a high capacity for binding the DNA. Nearly 100% 
recovery of DNA was obtained from the surface of the nanocomposite, whereas <10% was 
recovered from the magnetite core. It was possible to bind and elute approximately the same 
quantity of DNA using half the amount of the mesoporous silica-magnetite composite, as 
compared to classical amorphous silica-magnetite materials (Bruce et al., 2004).  
Specifically in enzyme immobilization, it is known that because of the low enzyme loading 
on the conventional magnetic beads, more and more attention was paid to the magnetic 
mesoporous support. Magnetite mesoporous silica hybrid support was fabricated by 
depositing magnetite and MCM-41 nanoparticles onto polystyrene beads using the layer-by-
layer (LBL) method. The incorporation of magnetite gives an additional magnetic property 
to the hollow mesoporous silica shells. This perfect combination of mesoporous material 
properties with a magnetic property improves the enzyme immobilization (Xie et al., 2009). 
Another field of interest in applications that has gained prominence in the biological area is 
the use of these systems in studies of drug delivery. 
3.2 Controlled release of drugs 
The idea of controlled release of biologically active substances began to be used in the 1950s 
with the advent of polymeric materials. The potential advantages of controlled release 
systems include: (i) localized release of drugs in a particular compartment of the body, 
thereby decreasing the systemic level of the drug, (ii) maintaining constant levels of drug in 
the body, resulting in greater efficiency in the use of the agent (i.e., it is necessary to lower 
the concentration of the drug to produce the same effect as in conventional systems), (iii) 
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preservation of the medicines that are quickly destroyed by the body (this is particularly 
important for biologically sensitive molecules such as proteins), (iv) lower frequency of 
administration of the active agent, enhancing patient comfort and effectiveness of treatment 
(Langer, 1990; Ogawa & Plepis, 2002). Besides the polymeric matrix, other controlled release 
systems based on different materials have been intensively studied in recent years, such as 
bioceramic and composites. Some examples are antibiotics like gentamicin, released from 
the matrix composed of calcium phosphates and poly(DL-lactide) (PLA) (Baro et al., 2002) 
and from the composite of hydroxyapatite/collagen (Martins & Goissis, 2000), and anti-
neoplastic agents like cisplatin, released from calcium phosphate (CaP) nanoparticles 
(Barroug et al., 2004). 
The porosity of conventional matrices is highly heterogeneous due to complex chemical 
composition, which presents as a great disadvantage the difficulty of ensuring 
homogeneous drug distribution through the matrix, affecting the release rate. Therefore, the 
need to address this disadvantage has led to improvements in this field through the use of 
ordered mesoporous materials, chemically homogeneous, which have well defined porosity. 
In this context, we have reported the influence of magnetic nanoparticles on drug release 
kinetics of three model drugs: cisplatin, carboplatin, and atenolol under in vitro. In this work 
(Souza et al., 2009), magnetic nanoparticles embedded into mesoporous silica were prepared 
in two steps: first, magnetite was synthesized by oxidation-precipitation method, and next, 
the magnetic nanoparticles were coated with mesoporous silica by using nonionic block 
copolymer surfactants as structure-directing agents. The SEM images of magnetite in Figure 
5 show that the material has uniform morphology and particle size distribution. In addition, 
some particle clusters may be observed due to the magnetic interaction between the 
particles. The regular octahedral morphology indicates that the particles are well 
crystallized. Figure 5.b shows the morphology of SBA-15. It consists of vermicular-shaped 
particles. In contrast, the nanocomposite presents spherical morphology. This may be 
attributed to the presence of the magnetite silica-coated nanoparticles. The average size of 
the spherical particles varied from 0.139 to 0.476 μm. Particles smaller than the human body 
capillary diameter (8 μm) are suitable for intravenous drug-delivery injection. The desired 
particle size range for a specific application may be selected by nanoparticle centrifugation 
at a controlled rate. 
Drug release was studied with and without a magnetic field in two experiments: a) with a 
constant magnetic field and b) with an alternating magnetic field. To simulate drug release 
in the presence of a magnetic field, a NdFeB magnet (0.250 T) was used in the first 
experiment, and in the second one, a low-frequency alternating magnetic field was obtained 
 
 
Fig. 5. SEM of (a) magnetite, (b) pure SBA-15, and (c) SBA- 15/Fe3O4 
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with a magnetic cavity composed of a Helmholtz coil connected to a direct current source 
coupled to a frequency generator and a Hall probe for measuring the magnetic field. The 
following frequencies were used: 15, 30, 45, 60, 100, and 300 Hz with a 17 mT magnetic field.  
The application of an alternating magnetic field provokes the vibration of the magnetic 
particles and the quick release of large quantities of drugs. The measures presented here are 
designed to assess the influence of the application of low frequency (≤300 Hz) alternating 
magnetic fields (170 Oe) on drug release. Figure 6a shows the release profiles of cisplatin 
without a magnetic field, with a constant magnetic field, and an alternating magnetic field 
up to 300 Hz. Drug release was more effective and faster in the alternating magnetic field, 
Figure 6. The alternating magnetic field showed a large influence on the cisplatin release 
profile. These results can be explained by the possible interaction of the drugs with the 
magnetite nanoparticles, possibly due to the incorporation of cisplatin into the mesopores 
and its interaction with the surface of the magnetic nanoparticles. 
Another promising application for these materials is in magnetic hyperthermia. 
3.3 Magnetic hyperthermia 
Hippocrates (460–370 BC) believed that any disease could be cured by heating the patient’s 
body (Ito et al., 2005). Since 1957, hyperthermia, a modality of cancer treatment with an 
elevated temperature between 41 and 45 ºC with a treatment time of at least 30 min, has 
received considerable attention due to its clinical efficacy, such as minimizing clinical side 
effects and the possibility of selectively destroying a localized or a deeply seated malignant 
cancer tumor (Bae et al., 2009). 
Cancer cells generally perish at around 43 ºC because their oxygen supply via the blood 
vessels is not sufficient, whereas normal cells are not damaged at even higher temperatures. 
In addition, tumors are more easily heated than the surrounding normal tissues, since the 
blood vessels and nervous systems are poorly developed in the tumor. Therefore, 
hyperthermia is expected to be a very useful cancer treatment with few side effects. Various 
techniques for heating the tumors, such as treatments with hot water, infrared rays, 
ultrasound, and microwaves have been attempted. However, deep-seated tumors cannot be 
heated effectively and locally using these techniques (Kawashita et al., 2005). 
 
 
Fig. 6. Release profile of the nanocomposite/cisplatin system without a field, in a constant 
field, and in an alternating field. 
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The biggest problem with this treatment is that it is not selective, i.e., when subjected to 
hyperthermia for tumor treatment, it also affects normal cells adjacent to the tumor. Thus, 
there is a need to develop a tumor-specific hyperthermia for tumor cells.  
Some researchers have proposed the concept of “intracellular” hyperthermia and have 
developed submicron magnetic particles for inducing hyperthermia. This concept is based 
on the principle that under an alternating magnetic field (AMF), a magnetic particle can 
generate heat by hysteresis loss (Ito et al., 2005).   
There are at least three different mechanisms by which magnetic materials can generate heat 
in an alternating field (Kalambur et al., 2005): (i) generation of eddy currents in bulk 
magnetic materials, (ii) hysteresis losses in bulk and multi-domain magnetic materials, and 
(iii) relaxation losses in ‘superparamagnetic’ single-domain magnetic materials. The 
mechanisms (i) and (ii) contribute very little to the heating system of particles with a single-
domain. The mechanism that contributes to significant heating of these particles, therefore, 
is the relaxation mechanism (iii). Relaxation losses in single-domain magnetic nanoparticles 
fall into two modes: rotational (Brownian) mode and Néel mode (Figure 7). In the Néel 
mode, the magnetic moment originally locked along the crystal easy axis rotates away from 
that axis towards the external field. The Néel mechanism is analogous to the hysteresis loss 
in multi-domain magnetic particles, whereby there is an ‘internal friction’ due to the 
movement of the magnetic moment in an external field that results in heat generation. In the 
Brownian mode, the whole particle oscillates towards the field with the moment locked 
along the crystal axis under the effect of a thermal force against a viscous drag in a 
suspending medium. This mechanism essentially represents the mechanical friction 
component in a given suspending medium.  
Kawashita and coworkers (Kawashita et al., 2005) studied magnetite microspheres with 
capacity heat generation. Two kinds of microspheres were synthesized: (a) magnetite 
microspheres formed by melting powders in high-frequency induction thermal plasma, and 
(b) silica glass microspheres formed by precipitation from an aqueous solution. In case (a), 
the magnetite microsphere diameter was 20 to 30 μm, with heat generation capacity of 10 
W/g, under 300 Oe and 100 kHz; in case (b), the silica glass microspheres coated with 
magnetite presented average size of 25 μm, while the average size of magnetite crystallites 
deposited on the silica surface was estimated at 50 nm. In the latter case, the heat generation 
was estimated to be 41 W/g, under 300 Oe and 100 kHz, showing that the silica/magnetite 
microsphere system is a promising one for hyperthermic treatment of cancer. 
There is a possibility of a second application for this system. The controlled drug delivery 
could be triggered by thermomagnetic action, adjusting the magnetic field and frequency. 
 
 
          (a)     (b)    (c) 
Fig. 7. (a) Induction Field schema for magnetic material in an AC coil. (b) and (c) Relaxational 
losses leading to heating in an alternating field (H): (b) Néel mode; (c)Brownian mode.  
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Considering these points, Hu and coworkers studied magnetic-sensitive silica nanospheres 
for ibuprofen release by controlled bursting to a therapeutically effective concentration by a 
high-frequency magnetic field (HFMF) (Hu et al., 2008). The acceleration of the rotation of 
magnetic nanoparticles deposited on the silica matrix generates heat energy; the HFMF 
enlarges the nanostructure of the silica matrix, producing porous channels that cause the 
drug to be released easily. Thus, nanospheres showed a marked ibuprofen release profile, 
with 180-190 min of release, when the system was triggered for 10 min in a high-frequency 
magnetic field (HFMF). This profile was compared with a control group of silica 
nanospheres without magnetic iron incorporation. The cumulative release of ibuprofen from 
silica nanospheres (Si:Fe = 1:1) was measured, both with and without magnetic stimulation 
of 50 kHz applied at the four specific times, and showed that after the magnetic stimulation, 
a significant increase in the amount of drug released was observed at each time interval. 
A small number of studies have been conducted with mesoporous silica/magnetic particles 
systems for hyperthermia applications. Recently, we reported the synthesis of 
nanocomposite-based SBA-15 and magnetite nanoparticles by the wet impregnation method 
of an iron precursor (Fe3(SO4)3) into a silica framework (Souza et al., 2010). Iron oxide was 
formed inside the porous structure, thus producing the magnetic device.  
The spontaneous magnetization of the nanocomposite is 10.31 Am2 kg-1, which is lower than 
that of magnetite (83.98 ± 2.2 Am2 kg-1), because the nanoscale particles form a single 
magnetic domain. The magnetic properties obtained by 57Fe Mössbauer spectroscopy (figure 
not given) showed that the nanocrystals present superparamagnetic characteristics. 
Tests of magnetic hyperthermia were performed. For this, AC magnetic-field-induced 
heating was measured both in the solid material and in an aqueous solution under different 
applied magnetic fields: 105 Oe (8.36 kA m-1) and 168 Oe (13.37 kA m-1).  
Figure 8 shows the time-dependent temperature curves of the dry nanocomposite for 198 
kHz and magnetic fields of 105 and 168 Oe AC. When the sample was exposed to an AC 
magnetic field for 30 min, its temperature ranged from 23 to 32.87 ºC in the 168 Oe AC 
magnetic field and from 23 to 25.16 ºC in the 105 Oe, showing its dependence on the 
magnetic field. This figure shows a relatively sharp increase in temperature in the beginning 
of heating. Moreover, a nearly steady state regime is established after 10 min under 168 Oe, 
reaching a temperature range of ΔTmax = 9.87 ºC. 
 
 
Fig. 8. Time-dependent temperature curves of the nanocomposite under 198 kHz and 
magnetic fields of 168 Oe (13.37 kA.m-1) and 105 Oe (8.36 kA.m-1). 
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When dispersed in water, the difference in the temperature of the nanoparticles between the 
starting ambient temperature and after 30 min of exposure to the magnetic field was 21 ºC 
under 168 Oe and 3 ºC under 105 Oe. Considering the results obtained for the dry 
nanoparticles and those dispersed in water in the 168 Oe magnetic field, Figures 9a and 9b, 
we notice a small increase in temperature for the former, resulting in ΔTmax = 9.87 ºC, and 21 
ºC for the latter. This behavior can be explained based on the total surface area of the 
magnetic nanoparticles and their ability to generate heat. If the magnetic nanoparticles are 
well dispersed in water, their specific surface area increases, as does the convective heat 
transfer rate to the fluid.  
The amount of heat generated by pure water in 168 Oe AC magnetic fields was measured to 
investigate more precisely the effect of water on the increase in the temperature of the 
dispersed nanoparticles. According to Figure 9b, although pure water contributes to a slight 
rise in temperature, from 23 to 29 ºC, heat generation is affected by the sample medium. This 
property of the nanoparticles dispersed in water was in fact measured after sonicating the 
solution for 30 min. The measured temperatures of the nanoparticle suspension after 
sonication and under 168 Oe AC magnetic field increased to 47.5 ºC after 30 min of assay, 
presenting a ΔTmax of 24.5 ºC.  
The principle of hyperthermia is to heat a body region affected by cancer to temperatures 
between 43 and 45 ºC. At these temperatures, the growth of cancerous cells can be halted. 
Thus, a temperature variation of ΔTmax = 9.87 ºC would be sufficient, based on a body 
temperature of 37 ºC. Considering all the measurement conditions used in this work, heat 
generation can be controlled in selected magnetic particles by adjusting the magnetic field 
and choosing an appropriate medium. 
 
Fig. 9. (a) time-dependent temperature curves of the nanocomposite under 198 kHz and 
magnetic fields of 168 Oe and 105 Oe; (b) heating-induced by magnetic field of 
nanocomposite in different situations to 168 Oe compared with pure water, used as a 
control.  
4. Functional hybrid mesoporous silica/poly(n-isopropylacrilamide) useful for 
drug delivery systems 
The second category of multifunctional materials deals with organic-inorganic hybrids 
systems based on mesoporous materials and stimuli-responsive polymers. Recent studies 
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have made fundamental proposals for development of hybrids materials based on polymer 
and mesoporous silica. Many different polymers have been encapsulated into the pores 
structure of the mesoporous materials, and different procedures were used for 
encapsulation. Recently, strategies for development of hybrids based on ordered 
mesoporous silica and stimuli-responsive polymers have been reported in the literature 
(Tian & Yang, 2009; Fu et al., 2007;  Liu et al., 2009; Gao et al., 2009; Sousa et al. 2010).These 
stimuli-responsive polymers show abrupt changes in their swelling behavior in response to 
small changes in environmental parameters such as temperature, pH, solvent composition, 
electric fields, etc. They have received much attention due to their potential applications in 
numerous fields. Among these stimuli-responsive polymers, the most important systems 
from a biomedical point of view are those sensitive to pH and/or temperature, because 
variables such as low pH and elevated temperatures are found in the body (Qui & Park, 
2001). 
One of the most studied temperature-responsive polymers is poly(N-isopropylacrylamide) 
[P(N-iPAAm)], which swells to a large extent in water, at a low temperature, and shrinks as 
the temperature is increased, showing a first-order phase transition around 33 ºC, behaving 
as a polymer solution with a lower critical solution temperature (LCST) (Freitas & Cussler, 
1987). Figure 10 shows this phase behavior schematically. This interesting phase behavior of 
a dramatic dependence of the swelling volume on temperature and a discontinuous 
transition has attracted the interest of many researchers all over the world in past years. 
Studies on the thermodynamic behavior of this system (Marchetti et al., 1990; Sousa, 1993; 
Sousa, 1995; Nakamoto, et al., 1996), different potential applications (Wu et al., 1996; Jin, et 
al., 1995), and permeability to small solutes (Palasis & Gehrke, 1992; Mukae, et al., 1993) 
have been reported. 
The thermodynamics of polymer gels describes the swelling equilibrium as a result of two 
opposite contributions: the change in the free energy of mixing as the gel is in contact with a 
solvent and the change in the elastic free energy due to the elongation of the network as the 
gel swells, absorbing solvent (Ogata, 1995). The understanding of the gels’ elastic structure 
is, therefore, fundamental. This structure is directly related to the crosslinking density and 
polymer-polymer interactions. 
 
T > 32ºC
T < 32ºC
 
Fig. 10. Schematic representation of the phase behavior of P(N-iPAAm). 
By utilizing this interesting phase behavior, P(N-iPAAm) can be used in biomedical 
applications such as DDS (Hoffman, 1987; Peppas & Langer, 2003). Furthermore, the interest 
in the use of P(N-iPAAm) in biomedical applications originates from a number of 
advantages that this presents for use as a biomaterial, such as biocompatibility, specific 
diffusive properties, elastomeric consistency, and low interfacial tension, among others. 
Hybrid functional nanosystems based on silica- P(N-iPAAm) have attracted much attention 
for control of molecular transport, including drug release, because a self-regulated delivery 
www.intechopen.com
 Advances in Diverse Industrial Applications of Nanocomposites 
 
190 
allows a drug to be released when it is needed. Thus the encapsulation of P(N-iPAAm) in 
ordered mesoporous silica has been of particular interest in the drug delivery area, since 
that combine the advantages of the mesoporous silica (thermal and mechanical stability, 
biocompatibility and textural properties) with the P(N-iPAAm) ability to swell or shrink in 
temperatures close to physiological temperature. Compared to the sustained-release system, 
the thermo-responsive controlled release system can realize a controlled release pattern, 
which can improve the therapeutic efficacy. However, studies on ordered mesoporous 
silica-thermoresponsive P(N-iPAAm) hybrids for use as DDS are few. To the best of our 
knowledge, only a small number of papers concerning a responsive-carrier-system-based 
mesoporous silica and P(N-iPAAm) for use in the drug delivery area has been reported up 
to the present (Zhou et al. 2007; Yang et al., 2008; You et al., 2008; Liu et al., 2009; Zhu, et al., 
2009; Sousa et al., 2010).  
Chang and co-authors (Chang et al., 2004) report the systematic application of the ordered 
mesoporous materials to smart controlled drug release using the thermoresponsive P(N-
iPAAm) hybrid mesoporous structures. The P(N-iPAAm) hybridized mesoporous materials 
were prepared by the radical-initiated polymerization with N-iPAAm monomers on 
modified mesoporous silica surface with different pore sizes (10, 17, 30 nm). Indomethacin 
was used to study the thermosensitive drug release from hybrid. The drug release from 
hybrid materials was investigated during stepwise temperature changes between 25 and 40 
ºC and measurement of the concentration in a UV-Vis spectrophotometer at different time 
intervals. The release profile showed a sustained positive thermoresponsive drug release. 
When the temperature was increased and maintained at 40 ºC, a nearly constant release 
pattern was observed and a rapidly decreased release was observed on the temperature 
change to 25 ºC. According to the nanodiffusion mechanism proposed by the authors at a 
low temperature, the drug is trapped in the polymer and in the porous structures, and the 
polymers swell to prevent the drug from being significantly released into the media. When 
the temperature is increased above the LCST of P(N-iPAAm), the polymers shrink to 
squeeze the drug into the porous channels, and open the pore structure. Although a large 
amount of drug may be squeezed out of the polymer above the LCST, the amount released 
into the media did not show a peak, because diffusion of the drug through the porous 
channels is the limiting mechanism to control the drug release, rather than the phase 
behavior of the P(N-iPAAm).  
In this same sense, Zhou et al. investigated a system based on stimulus-responsive P(N-
iPAAm) inside a mesostructured cellular foam (MCF-PNIPA) as a device for drug delivery 
(Zhou et al., 2007). Ibuprofen (IBU) was loaded in MCF-PNIPA samples at 45 ºC during 48 h. 
Drug release studies were performed by soaking samples in a solution with pH maintained 
at 7.4 and stepwise changing the temperature between 10 and 60 ºC. The release process was 
followed spectroscopically. Loading and release data suggested that the multilayer 
polymers inside the pores of the MCF apparently formed an internal cavity for drug 
molecules increasing the IBU storage capacity, in addition to responding to changes in 
external temperature. A possible mechanism of the drug storage and release profile from the 
system was developed by the authors, and according to this mechanism, at a low 
temperature, the drugs are confined in the pores owing to expansion of the P(N-iPAAm) 
molecular chains and the formation of hydrogen bonding between P(N-iPAAm) and IBU. 
With an increasing temperature, the polymer chains are hydrophobic and swell within the 
pore network, resulting in the collapse of hydrogen bonds and pushing the drug molecules 
from the pores. Figure 11 shows this dependence of IBU amount released on temperature.  
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Fig. 11. The dependence of release amounts of IBU on temperature. Data obtained from 
(Zhou et al., 2007). 
Furthermore, in 2007, a novel synthesis of a multi-functional delivery system based on 
ordered mesoporous silica SBA-15 with magnetic particles formed in situ and thermo-
sensitive P(N-iPAAm) - m-SBA–PNIPA was reported. They employed hydrophilic FeCl2 as 
an additional precursor to fabricate magnetic particles inside SBA-15 via surfactant template 
sol–gel process, and the polymerization of N-iPAAm was implemented inside the pores of 
SBA-15 with a magnetic particle system. Ibuprofen also was encapsulated inside the sample 
m-SBA–PNIPA and the in vitro delivery assays were performed according to the procedure 
previously described by Zhou et al., stepwise changing the temperature between 9 and 45 
ºC. The system exhibited a pronounced transition at approximately 17 ºC, and when the 
temperature was between 7 and 11 ºC, a drug release of 40.5% from the m-SBA–PNIPA was 
observed. As the temperature rose to 17 ºC, the polymer shrank, leading to the progressive 
increase of the release rate. Similar results were found for the systems previously reported 
for Chang and Zhou et al., where a positive thermosensitive release profile was observed. 
However, this delivery system did not show characteristic bulk behavior with respect to 
their LCST, and as mentioned by the authors, this system is not suitable for in vivo 
application but could probably be used in many others fields. 
Another kind of magnetic mesoporous silica/P(N-iPAAm) nanocomposite was also 
prepared recently by Liu et al. (Liu et al., 2009), who reported a strategy to prepare 
core/shell-structured magnetic mesoporous silica microspheres combining three advantages 
into one single entity. This strategy involves a Fe3O4 magnetic nanoparticle as the core, 
mesoporous silica as a sandwiched layer, and cross-linked thermosensitive poly(N-
isopropylacrylamide/N-hydroxymethyl acrylamide) - P(NIPAM-co-NHMA) copolymer as 
an outer shell. Zn(II) phthalocyanine tetrasulfonic acid (ZnPcS4), a photodynamic therapy 
(PDT) drug, was used as a model drug to assess the drug loading and controlled release 
behavior of the core/shell composite microspheres. Drug release studies were performed by 
soaking loaded microsphere hybrids in a solution with pH maintained at 7.4 and measuring 
the cumulative release amount of ZnPcS4 after 24 h at different temperatures. These 
composite microspheres with different amounts of the hydrophilic co-monomer exhibited a 
temperature-dependent drug release behavior (Figure 12) where the cumulative release 
amount after 24 h at 39 ºC was almost three times higher than that at 37 ºC for two samples 
prepared with different monomer ratios. According to the authors, the significant difference 
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in cumulative release amount at different temperatures indicated a potential application in 
the therapy of malignant tumors. For instance, the M-MSN/P(NIPAM-co-NHMA) 
composite microspheres with superparamagnetic cores and temperature-sensitive shells 
could be guided by an external magnetic field to the target site, undergo a swelling– 
shrinking transition, and release the loaded drug rapidly because of the temperature 
difference between malignant tumor tissue and normal tissue, or because of the temperature 
difference caused by the magnetocaloric effect in the alternating-current magnetic field. 
Yang et al. (2008) synthesized a potential material for applications in intercellular imaging, 
as biomarkers and biosensors. This material is based on mesoporous silica nanoparticles 
(MSNs) coated with poly(N-isopropylacrylamide) - MSN@PNIPAM.  The MSN@PNIPAM 
was synthesized by atom transfer radical polymerization (ATRP) on the surface of MSN 
through the ‘‘grafting-from’’ method. The thermoresponsive properties of the 
MSN@PNIPAM were studied by turbidimetry and dynamic light scattering (DLS) 
measurements and the measured LCST of MSN@PNIPAM material was about 32ºC, 
consistent with pure PNIPAM in water. A fluorescent dye (FITC) was used as a model guest 
molecule to test the encapsulation and release ability of the MSN@PNIPAM particles. FITC 
was entrapped by the stretched polymer chains below LCST, and locked inside the MSNs 
above LCST. Additionally, the authors took MCF-7 cells to investigate the behavior of FITC 
MSN@PNIPAM in cells. The confocal laser scanning microscopy images showed that some 
particles had been internalized into the cells and localized in the cell cytoplasm. FITC was 
locked inside the MSN particles during the cell endocytosis process because the cell culture 
temperature was higher than LCST. The cytotoxicity of MSN@PNIPAM was also 
investigated and the results suggested that MSN@PNIPAM particles had negligible 
influence upon the growth of cells showing very low cytotoxicity. 
 
 
Fig. 12. Cumulative drug release of drug-loaded systems in PBS solution as a function of 
temperature. Data obtained from (Liu et al., 2009). 
We recently reported the control of drug release in response to temperature in a system 
based on a temperature-responsive hydrogel, poly(N-isopropylacrylamide) [P(N-iPAAm)], 
inside a mesoporous silica SBA-15 (Sousa et al., 2010). The incorporation of polymer phase 
in the mesoporous silica led to a significant change in the structural properties of this 
system. However, the polymerization and pore filling did not destroy the ordered 
hexagonal structure of SBA-15, as shown by TEM images (Figure 13), but the surface area, 
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pore size, and pore volume of the hybrid decreased due to the introduction of the polymer. 
The primary mesopore volume and total pore volume of [SBA-15/P(N-iPAAm)] (0.42 and 
0.48 cm3 g-1) were lower than the SBA-15 values (0.83 and 0.96 cm3 g-1), respectively. The 
pore diameter decreased from 5.70 to 3.76 nm (~34%).  
 
  
                                                       (a)                                               (b) 
Fig. 13. TEM images of [SBA-15/P(N-iPAAm)] (a) viewed along the pore axis and (b) 
viewed perpendicular to the pore axis. 
Figure 14 shows the nitrogen adsorption isotherms and the pore size distribution for pure 
SBA-15 and for the [SBA-15/P(N-iPAAm)] hybrid. The analysis of the isotherms and the 
respective adsorption and desorption-derived curves reveal a reduction in symmetry and 
the occurrence of a stepwise desorption phenomenon in the hybrid sample, suggesting 
bimodal porosity. This behavior is often referred to as a pore blocking phenomenon and is 
attributed to the formation of porous plugs in the ordered channels of SBA-15. After 
polymerization, the shape of the hysteresis loop in the N2-sorption isotherm displays a 
broadening suggestive of a reduction in pore size uniformity. Indeed, the desorption branch 
shifted towards lower relative pressure P/P0 with a concurrent decrease in the pore 
diameters. Such a decrease can be verified by analyzing the inflection points of the 
desorption isotherms and the pore size distribution graphs. The desorption isotherm of 
mesoporous silica presented an inflection point of 0.64 at P/P0. On the other hand, the 
hybrid sample presented two inflection points of 0.60 and 0.47 around P/P0; this means that 
the presence of an organic phase in the silica matrix provoked a shift to a smaller relative 
pressure related to a decrease in pore size. 
Atenolol was used to study thermosensitive drug release by hybrid sample. A continued 
flow was employed to assay the atenolol release profile of this system. Release studies were 
conducted at four different temperatures: 10, 25, 30, 35, and 40 ºC in a simulating body fluid 
(SBF). A control experiment was conducted in a similar manner for SBA-15. Drug loading 
was determined through UV–Vis analysis in SBF solution by measuring the absorbance of 
atenolol at 274 nm. The cumulative drug release profiles (Figure 15) showed clear 
differences between the studied materials as a function of the temperature. In this figure, the 
discontinuity in the release profile of the hybrid system as a function of temperature is 
clearly observed (indicated by arrows above the respective curves). This response in the 
hybrid system is strongly indicative of the polymer phase behavior. A quasilinear behavior 
in the release profile of SBA-15 as a function of temperature is also displayed in Fig. 15b. As 
expected, the release of atenolol from pure SBA-15 is temperature dependent (Fig. 15a). This 
behavior can be explained considering that the overall drug delivery into the medium is 
www.intechopen.com
 Advances in Diverse Industrial Applications of Nanocomposites 
 
194 
controlled by diffusion through the porous channels. However, as shown by the release 
profile, delivery seems to be less effective at temperatures as low as 10 ºC, since this system 
presents a comparatively lower delivery rate at this temperature. In this case, the drug was 
trapped in the porous structures of the silica network. This may be explained by two 
simultaneous behaviors: the diffusion rate in the mesoporous material, which is severely 
affected at this temperature, and the drug interaction with the mesoporous silica through 
hydrogen bonds due to the affinity of the functional groups amine, amide, and hydroxyl of 
the atenolol molecules and the silanol groups present in the mesoporous silica, which is 
ascribed to the relatively polar hydrophilic character of the drug. At this temperature (10 
ºC), the thermodynamic conditions are not enough to destabilize the hydrogen interactions 
between the hydrophilic groups of the drug and the silanol groups of silica. The atenolol, 
then, has a tendency to remain in the silica nanostructure. When the temperature was raised 
to 25 ºC, the interactions between the drug molecules and the silica surface were affected, 
causing its rupture and a major release of atenolol into the medium. At 40 ºC, this 
phenomenon persists and is more evident, as demonstrated by the release profile in Fig. 15a.  
 
 
                                                (a)                      (b) 
Fig. 14. (a) N2 adsorption-desorption isotherms and (b) Pore size distribution of SBA-15 and 
[SBA-15/P(N-iPAAm)]. 
The analysis of the performance of the hybrid system as a drug delivery device (Fig. 15b) 
shows that the release profiles of [SBA-15/P(N-iPAAm)]vary with temperature, as 
compared to that of pure SBA-15. At 25 ºC, the release rate was high, followed by a 
sustained release rate; a similar behavior was observed at 10 ºC. However, when the 
temperature was increased to and maintained at 40 ºC, a slower and sustained release rate 
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was observed. Nevertheless, it rapidly decreased when the temperature was reduced to 35 
ºC. This behavior suggests that factors other than temperature affect drug release. These 
observations lead us to suggest that the drug release response of hybrid systems depends on 
temperature and the polymer phase behavior. The LCST of P(N-iPAAm) is around 35 ºC; 
when the temperature was lower than the LCST, the polymer swelled and drug release was 
faster. When the temperature was above the LCST, the polymer collapsed, acting as a 
diffusion barrier, and the drug release from the pores was significantly blocked. With the 
increase in temperature, an increase in drug diffusion would be expected; however, the 
increase in temperature provokes a contraction of the polymer network in the hybrid 
nanostructure. This contraction creates a physical barrier to the drug diffusion, thus 
decreasing its release to the medium. This temperature-dependent behavior becomes critical 
upon the complete collapse of the polymer chains at around 35 ºC, when the structure 
barrier to diffusion is the largest. This fact explains the great reduction in the release rate of 
atenolol from the hybrid system from 25 and 30 to 35 ºC. Above the LCST, the polymer does 
not present phase change anymore, remaining contracted without structural variation. The 
effect of temperature is illustrated in Fig. 15b, when it varies from 35 to 40 ºC, presenting a 
larger release of atenolol. Even though the release rate is high at this temperature, it is lower 
than at 25 and 30 ºC, as the polymer expanded and consequently presented a lesser barrier 
to the diffusion of atenolol. Therefore, below the LCST, the contraction phenomenon of the 
polymeric framework in the silica exerts a more significant influence than the temperature 
on the release of atenolol to the medium. Above the LCST, the conformational aspect of the 
polymer does not affect the process and the temperature becomes the dominant variable in 
the release process. 
 
 
                      (a)                                      (b) 
Fig. 15. Cumulative release profile of atenolol plotted against time and temperature for (a) 
SBA-15 and (b) [(SBA-15)/P(N-iPAAm)].  
A mechanism to explain the thermosensitive release profile was developed by the authors 
(Figure 16). Below the LCST, the polymer swelled and drug release was faster (situations a 
and b). With the increase in temperature, a decrease in release was observed. It was 
speculated that the suppression of the release is a result of the contraction of the hydrogel 
network with heating, which creates a physical barrier to the drug diffusion. This 
temperature-dependent behavior becomes critical upon the complete collapse of the 
polymer chains at around 33 ºC, when the structure barrier to diffusion is the largest 
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(situation c). Above the LCST (situation d), the polymer does not present phase change 
anymore, remaining contracted without structural variation, and the temperature becomes 
the dominant variable in the release process, increasing the release of atenolol.  
 
              (a and b)                (c)                            (d)  
Fig. 16. Schematic representation of the proposed mechanism to explain the thermosensitive 
release profile. 
It is important to note that this release mechanism is clearly different from those previously 
reported (Zhou et al., 2007; Zhu et al., 2007), since the major release rate was observed below 
the LCST, rather than above it (a negative thermosensitive release profile was observed). 
However, similar results were presented by You et al. (You et al., 2008), who studied the 
release of fluorescein as a function of the temperature from micro to mesoporous silica 
nanoparticle (MSN)/P(N-iPAAm) composites and obtained a greater release rate at 25 ºC, 
below LCST (Figure 17). 
 
Fig. 17. Release studies conducted at 20 and 38 ºC in PBS. Data obtained from (You et al., 
2008). 
5. Conclusion 
This review summarized the recent developments in the methods to synthesize 
polymer/mesoporous silica and iron nanoparticle/mesoporous silica nanocomposites. We 
developed an easy and direct synthesis route to obtain nanocomposites and hybrid 
functional nanosystems based on mesoporous silica. The applicability of this system as a 
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matrix for controlled drug delivery and also in magnetic hyperthermia was studied. The 
results indicate that different combinations of the ordered mesoporous silica have a 
potential to encapsulate bioactive molecules to use in biomedicine. The above results show 
that the composition and morphology of carrier materials and the external agents are 
important factors in influencing the drug delivery performance. However, a direct 
comparison of these results with those described by other research groups cannot be 
performed, since the systems were prepared from mesoporous matrices and by different 
procedures, including hybrid systems and with magnetic particles. Furthermore, the release 
assays were conducted differently, using drugs with distinct properties. 
In spite of this, we have shown that mesoporous silica-coated magnetite nanoparticles with 
these structural and magnetic characteristics, unobstructed pores and easy functionalization 
of the silica surface, seem to be promising material for hosting and further delivery, under 
appropriate conditions, of a variety of molecules of pharmaceutical interest. Hyperthermia 
tests indicated that the nanocomposite can be used as a matrix for localized hyperthermia 
treatment of cancers. Heat generation depended on the intensity of the AC magnetic field 
and the nanoparticle medium. 
On the other hand, even though there have been significant advances, studies involving the 
potential use of responsive hybrids in the area of controlled release of drugs are still 
incipient, and many properties of these materials are in the process of analysis, and 
synthesis procedures are being modified in order to gain greater control over these 
morphological and structural materials. Even though the pure mesoporous materials are 
potentially suitable for biomedical applications because they are biocompatible and resistant 
to biodegradation in cell media, the study of the biological response of responsive hybrids 
based on mesoporous materials is incipient, as in vivo assays depend heavily on parameters 
which are not well established, such as structural and morphological properties and their 
dosage forms.  
A substantial effort has been made recently to develop hybrids based on mesoporous silica 
nanospheres combined with iron nanoparticles as well responsive polymers that can be 
directly targeted at the cells, releasing a given active principle in response to variations in 
some external stimulus. A more in depth study considering our systems with regard to 
morphological parameters and biological behavior is planned in the future. 
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